These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2574068)

  • 21. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission.
    Frommberger UH; Bauer J; Haselbauer P; Fräulin A; Riemann D; Berger M
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(4):228-33. PubMed ID: 9332905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depressive states occurring during the neuroleptic treatment of schizophrenia.
    Möller HJ; von Zerssen D
    Schizophr Bull; 1982; 8(1):109-17. PubMed ID: 6122264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant usage in schizophrenia.
    Plasky P
    Schizophr Bull; 1991; 17(4):649-57. PubMed ID: 1687176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The appropriateness of routine medication treatment for schizophrenia.
    Young AS; Niv N; Cohen AN; Kessler C; McNagny K
    Schizophr Bull; 2010 Jul; 36(4):732-9. PubMed ID: 18997159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of adjunctive verapamil administration in chronic schizophrenic patients.
    Bartko G; Horvath S; Zador G; Frecska E
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(3):343-9. PubMed ID: 1677775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tardive dyskinesia and positive and negative symptoms of schizophrenia. A study using instrumental measures.
    Yuen O; Caligiuri MP; Williams R; Dickson RA
    Br J Psychiatry; 1996 Jun; 168(6):702-8. PubMed ID: 8773812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug compliance and health locus of control in schizophrenia].
    Combes C; Feral F
    Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical correlates of olfactory hallucinations in schizophrenia.
    Langdon R; McGuire J; Stevenson R; Catts SV
    Br J Clin Psychol; 2011 Jun; 50(2):145-63. PubMed ID: 21545448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
    Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
    J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depression in patients with schizophrenia during an acute psychotic episode.
    Tapp A; Kilzieh N; Wood AE; Raskind M; Tandon R
    Compr Psychiatry; 2001; 42(4):314-8. PubMed ID: 11458306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brief psychoeducation for schizophrenia primarily intended to change the cognition of auditory hallucinations: an exploratory study.
    Shiraishi N; Watanabe N; Kinoshita Y; Kaneko A; Yoshida S; Furukawa TA; Akechi T
    J Nerv Ment Dis; 2014 Jan; 202(1):35-9. PubMed ID: 24375210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two factors of experienced deficits in schizophrenia and their relationships with positive, negative, and depressive symptoms.
    Iwawaki A; Narushima K; Ota K; Okura T; Tsuchiya K; Takashima A
    Compr Psychiatry; 1998; 39(6):386-91. PubMed ID: 9829147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyproheptadine in treatment-resistant chronic schizophrenics with prior negative response to fluoxetine.
    Bacher NM; Sanzone MM; Kaup B
    J Clin Psychopharmacol; 1994 Dec; 14(6):424-5. PubMed ID: 7884024
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessing the effects of atypical antipsychotics on negative symptoms. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():28-34. PubMed ID: 9766617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rating depression in schizophrenia. A comparison of a self-report and an observer report scale.
    Addington D; Addington J; Maticka-Tyndale E
    J Nerv Ment Dis; 1993 Sep; 181(9):561-5. PubMed ID: 8245924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression in first-episode schizophrenia.
    Koreen AR; Siris SG; Chakos M; Alvir J; Mayerhoff D; Lieberman J
    Am J Psychiatry; 1993 Nov; 150(11):1643-8. PubMed ID: 8105706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.